Research Tracker›Biomarker Atlas›Marker Pages›ZnT8 autoantibodies

ZnT8 autoantibodies: biomarker evidence

ZnT8 autoantibodies appears in 1 entry of the OSMF biomarker atlas, covering Type 1 Diabetes. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Type 1 Diabetes

Where ZnT8 autoantibodies is reported

ConditionDirectionCompared againstAssociated symptomsSource
Type 1 Diabetes↑ elevatedT1D patients vs non-diabetic controls—Bhola et al. 2021

Frequently asked questions

In which conditions is ZnT8 autoantibodies altered?

In the OSMF atlas ZnT8 autoantibodies is reported in Type 1 Diabetes. It is elevated in 1 across 1 entries.

Is there a standard clinical test for ZnT8 autoantibodies?

The atlas entries for ZnT8 autoantibodies do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal ZnT8 autoantibodies result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). ZnT8 autoantibodies across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/znt8-autoantibodies.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-03 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.